MERCK SHARPE & DOHME LTD has a total of 27 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States and United Kingdom. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are CURTANA PHARMACEUTICALS INC, AHMED KAMAL and MORPHIC THERAPEUTIC INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Baker Raymond | 6 |
#2 | Chambers Mark S | 4 |
#3 | Macleod Angus M | 3 |
#4 | Kulagowski Janusz J | 3 |
#5 | Showell Graham A | 3 |
#6 | Saunders John | 3 |
#7 | Whiting Paul John | 3 |
#8 | Billington David C | 2 |
#9 | Macleod Angus Murray | 2 |
#10 | Le Bourdelles Beatrice | 2 |
Publication | Filing date | Title |
---|---|---|
US5719057A | Stably human transfected rodent fibroblast cell line expressing human GABA-A recepotors, and cloned human GABA-A receptor subunit CDNA sequences | |
US5405853A | Thiadiazoles useful in the treatment of senile dementia | |
US5324723A | Oxazoles and thiazoles for the treatment of senile dementia | |
US5328927A | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them | |
US5331089A | Peptides useful as tachykinin agonists | |
US5360802A | Benzodiazepine derivatives, compositions containing them and their use in therapy | |
US5208248A | Indazole-substituted five-membered heteroaromatic compounds | |
GB8607713D0 | Oxadiazoles |